Votes: SD HB1099 | 2026 | Regular Session

Bill Title: Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Sponsorship: Slight Partisan Bill (Republican 9-4)

Status: (Passed) 2026-03-10 - Signed by the Governor on March 10, 2026 H.J. 547 [HB1099 Detail]

Text: Latest bill text (Enrolled) [PDF]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
SenateDo Pass2026-03-0221120235PassedLinkView
SenateDo Pass2026-02-2560017PassedLinkView
HouseDo Pass2026-02-095870570PassedLinkView
HouseDo Pass2026-02-051300013PassedLinkView


feedback